CSIMarket
 


Inhibitor Therapeutics Inc   (HPPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

HPPI's Operating Income Growth by Quarter and Year

Inhibitor Therapeutics Inc 's Operating Income results by quarter and year




HPPI Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.64 -1.33 0.11
III Quarter September - -0.68 -1.18 -0.68
II Quarter June - -0.64 -0.88 -2.81
I Quarter March -0.39 -0.79 -1.17 -2.76
FY   -0.39 -2.75 -4.56 -6.14



HPPI Operating Income first quarter 2020 Y/Y Growth Comment
Inhibitor Therapeutics Inc in the first quarter recorded Operating Loss of $ -0.39 millions.

According to the results reported in the first quarter, Inhibitor Therapeutics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Inhibitor Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


HPPI Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Inhibitor Therapeutics Inc 's first quarter 2020 Operating Income $ -0.39 millions HPPI's Income Statement
Inhibitor Therapeutics Inc 's first quarter 2019 Operating Income $ -0.79 millions Quarterly HPPI's Income Statement
New: More HPPI's historic Operating Income Growth >>


HPPI Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Inhibitor Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's I. Quarter Q/Q Operating Income Comment
Despite the fact, that Inhibitor Therapeutics Inc in the I. Quarter 2020 admitted Operating Loss of $ -0.39 millions, it should be said, that those numbers show slight up side in contrast to the -0.64 millions in the forth quarter.

Within Biotechnology & Drugs industry Inhibitor Therapeutics Inc achieved highest sequential Operating Income growth. While Inhibitor Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's I. Quarter Q/Q Operating Income Comment
Although Inhibitor Therapeutics Inc in the I. Quarter 2020 revealed Operating Loss of $ -0.39 millions, management point out, that current results show slight up side relative to the -0.64 millions in the forth quarter.

Within Biotechnology & Drugs industry Inhibitor Therapeutics Inc achieved highest sequential Operating Income growth. While Inhibitor Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Inhibitor Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -2.34 $ -2.75 $ -3.44 $ -3.93 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
HPPI's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for HPPI's Competitors
Operating Income Growth for Inhibitor Therapeutics Inc 's Suppliers
Operating Income Growth for HPPI's Customers

You may also want to know
HPPI's Annual Growth Rates HPPI's Profitability Ratios HPPI's Asset Turnover Ratio HPPI's Dividend Growth
HPPI's Roe HPPI's Valuation Ratios HPPI's Financial Strength Ratios HPPI's Dividend Payout Ratio
HPPI's Roa HPPI's Inventory Turnover Ratio HPPI's Growth Rates HPPI's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Amedisys Inc -1.02 %$ -1.024 millions
Lemaitre Vascular Inc -1.85 %$ -1.849 millions
Hca Healthcare Inc -2.78 %$ -2.784 millions
Mettler Toledo International Inc -3.03 %$ -3.027 millions
Genesis Healthcare Inc -4.96 %$ -4.963 millions
Phibro Animal Health Corp -5.53 %$ -5.534 millions
Utah Medical Products Inc -5.80 %$ -5.803 millions
Pfizer Inc -7.00 %$ -7.000 millions
Illumina Inc -7.35 %$ -7.353 millions
Iqvia Holdings Inc -8.10 %$ -8.095 millions
Brookdale Senior Living Inc -10.57 %$ -10.570 millions
Abiomed Inc -11.22 %$ -11.219 millions
Tenet Healthcare Corp -11.86 %$ -11.860 millions
Bausch Health Companies Inc -13.59 %$ -13.589 millions
Icu Medical Inc -14.21 %$ -14.207 millions
Integra Lifesciences Holdings Corp -16.11 %$ -16.111 millions
U s Neurosurgical Holdings Inc -18.12 %$ -18.121 millions
Orgenesis Inc -18.61 %$ -18.615 millions
Pra Health Sciences Inc -19.74 %$ -19.744 millions
Integrated Biopharma Inc -22.39 %$ -22.393 millions
Procyon Corp -23.41 %$ -23.412 millions
Biolife Solutions Inc -24.64 %$ -24.644 millions
Immucell Corp -25.79 %$ -25.792 millions
Integrity Applications Inc -26.30 %$ -26.297 millions
Owens and Minor Inc -26.79 %$ -26.790 millions
Quest Diagnostics Inc -29.44 %$ -29.435 millions
Universal Health Services Inc -30.47 %$ -30.473 millions
Regional Health Properties Inc -34.86 %$ -34.860 millions
Community Health Systems Inc -41.80 %$ -41.799 millions
Synergy Chc Corp -44.87 %$ -44.869 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMRH's Profile

Stock Price

AMRH's Financials

Business Description

Fundamentals

Charts & Quotes

AMRH's News

Suppliers

AMRH's Competitors

Customers & Markets

Economic Indicators

AMRH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071